News

Dr. Vivek Goel is recognized in Canada and around the world as a leading public-health researcher, health-services evaluation expert, and champion for the use of research evidence in health policy making.

He also currently serves on the boards of the Vector Institute, TRIUMF, the Canadian Institute for Health Information, Canada Health Labs, and the Post Promise.

CBB members, George Shaker and Safieddin (Ali) Safavi-Naeini part of team that creates new technology that can quickly and accurately monitor glucose levels in people with diabetes without painful finger pricks to draw blood. 

New technology can quickly and accurately monitor glucose levels in people with diabetes without painful finger pricks to draw blood. 

A palm-sized device developed by researchers at the University of Waterloo uses radar and artificial intelligence (AI) to non-invasively read blood inside the human body.

We have an intimate relationship with technology. It is infused in our daily life, from our home and car to our finances and health care. As we welcome new technologies into our most personal spaces, there is a growing recognition that design-based thinking needs to consider ethics and the users it serves.

The University of Waterloo and the Medical Device Commercialization Centre (MDCC) have signed a Memorandum of Understanding.  This will allow medical device technologies developed at Waterloo to access the services of MDCC.

CBB welcomes and is supporting the 18th CSChE (Canadian Society for Chemical Engineering) Quebec-Ontario Biotechnology Meeting held at the University of Waterloo in Waterloo, Ontario on May 26-27, 2016.

Inaugural conference reflects on 100 years of heath care, looks to its future

Leaders in community health care, technology, research and entrepreneurship will gather next week to discuss the ways these areas intersect in medicine now and should in the future, while celebrating a milestone anniversary for one health-care facility in the region.

Professor Catherine Burns has been reappointed to a three-year term as Director of the Centre of Bioengineering and Biotechnology (CBB), according to an announcement by the Dean of Engineering, Pearl Sullivan and Dean of Science, Terry McMahon.